Nicotinamide adenine dinucleotide suppresses epileptogenesis at an early stage

The pathophysiologic mechanisms of epileptogenesis are poorly understood, and no effective therapy exists for suppressing epileptogenesis. Numerous reports have shown that nicotinamide adenine dinucleotide (NAD(+)) has neuroprotective effects, suggesting its potential use for treating epileptogenesi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sci Rep
Autors principals: Liu, Juan, Yang, Beimeng, Zhou, Pei, Kong, Yingying, Hu, Weiwei, Zhu, Geng, Ying, Weihai, Li, Weidong, Wang, Yun, Li, Shengtian
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5544671/
https://ncbi.nlm.nih.gov/pubmed/28779137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-07343-0
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars